Loading…
A Randomized Controlled Study of the Effects of Different Modalities of Narrow‐Band Ultraviolet B Therapy on the Outcome of Cultured Autologous Melanocytes Transplantation in Treating Vitiligo
Background Vitiligo is an acquired skin disorder with great social impact. It can be successfully treated using cultured autologous melanocytes transplantation. Objective To evaluate the effect of different modalities of narrow‐band ultraviolet B (NB‐UVB) therapy on the outcome of cultured autologou...
Saved in:
| Published in: | Dermatologic surgery 2014-04, Vol.40 (4), p.420-426 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c3634-9b8930aef4084f99a843c0e21f4732caa712f77f4d1e6eac02483a8a1e7a66393 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c3634-9b8930aef4084f99a843c0e21f4732caa712f77f4d1e6eac02483a8a1e7a66393 |
| container_end_page | 426 |
| container_issue | 4 |
| container_start_page | 420 |
| container_title | Dermatologic surgery |
| container_volume | 40 |
| creator | Zhang, Di‐min Hong, Wei‐song Fu, Li‐fang Wei, Xiao‐dong Xu, Ai‐e |
| description | Background
Vitiligo is an acquired skin disorder with great social impact. It can be successfully treated using cultured autologous melanocytes transplantation.
Objective
To evaluate the effect of different modalities of narrow‐band ultraviolet B (NB‐UVB) therapy on the outcome of cultured autologous melanocyte transplantation in treating vitiligo.
Methods
Patients undergoing cultured autologous melanocyte transplantation were randomly assigned to four different study groups. Group 1 underwent 20 sessions of NB‐UVB treatment before transplantation; Group 2 underwent 30 sessions of NB‐UVB treatment after transplantation; Group 3 underwent 20 sessions of NB‐UVB treatment before transplantation and 30 sessions after transplantation; Group 4 underwent only transplantation.
Results
Four hundred thirty‐seven patients were enrolled. Group 3 responded best, more than 90% repigmentation was achieved in 81.3% of patients, and 94.8% patients experienced 50% or greater repigmentation. Statistical analysis showed that there was a highly significant difference between the four groups (χ2 = 35.56, p |
| doi_str_mv | 10.1111/dsu.12444 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1514434399</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1514434399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3634-9b8930aef4084f99a843c0e21f4732caa712f77f4d1e6eac02483a8a1e7a66393</originalsourceid><addsrcrecordid>eNp1kctuEzEUhkeIipbCghdAXsJiWnvsuS3TtAWkXiSasB2dzhwnBs84-NIorHgEnolH4UnwJKEr6o3_Y33nP8f6k-QNoycsntPOhROWCSGeJUcsz0Qqyix_HjUti5TmLDtMXjr3lVKW1Zy-SA5Htijz_Cj5PSGfYehMr35gR6Zm8NZoHeWdD92GGEn8EsmFlNh6N5bnKmqLgyfXpgOtvMLt-w1Ya9Z_fv46i3Zkrr2FB2U0enJGZku0sIpuw9btNvjW9Dh2TYP2wcZxk-CNNgsTHLlGDYNpNz4azywMbhVrD17FdjXEJ4x6WJAvcbZWC_MqOZCgHb7e38fJ_PJiNv2YXt1--DSdXKUtL7hI6_sqfh5QCloJWddQCd5SzJgUJc9agJJlsiyl6BgWCC3NRMWhAoYlFAWv-XHybue7suZ7QOebXrkWddwO494Ny5kQXPB6RN_v0NYa5yzKZmVVD3bTMNqMkTUxsmYbWWTf7m3DfY_dI_kvowikO2BttEfrvumwRtssEbRf_tfwdM8rjZunJzfnd_Ndx1_IGrR5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1514434399</pqid></control><display><type>article</type><title>A Randomized Controlled Study of the Effects of Different Modalities of Narrow‐Band Ultraviolet B Therapy on the Outcome of Cultured Autologous Melanocytes Transplantation in Treating Vitiligo</title><source>Wiley Blackwell Journals</source><creator>Zhang, Di‐min ; Hong, Wei‐song ; Fu, Li‐fang ; Wei, Xiao‐dong ; Xu, Ai‐e</creator><creatorcontrib>Zhang, Di‐min ; Hong, Wei‐song ; Fu, Li‐fang ; Wei, Xiao‐dong ; Xu, Ai‐e</creatorcontrib><description>Background
Vitiligo is an acquired skin disorder with great social impact. It can be successfully treated using cultured autologous melanocytes transplantation.
Objective
To evaluate the effect of different modalities of narrow‐band ultraviolet B (NB‐UVB) therapy on the outcome of cultured autologous melanocyte transplantation in treating vitiligo.
Methods
Patients undergoing cultured autologous melanocyte transplantation were randomly assigned to four different study groups. Group 1 underwent 20 sessions of NB‐UVB treatment before transplantation; Group 2 underwent 30 sessions of NB‐UVB treatment after transplantation; Group 3 underwent 20 sessions of NB‐UVB treatment before transplantation and 30 sessions after transplantation; Group 4 underwent only transplantation.
Results
Four hundred thirty‐seven patients were enrolled. Group 3 responded best, more than 90% repigmentation was achieved in 81.3% of patients, and 94.8% patients experienced 50% or greater repigmentation. Statistical analysis showed that there was a highly significant difference between the four groups (χ2 = 35.56, p < .001). Homogeneous skin color was obtained on the repigmentation areas, and no scarring or other serious side effects were observed.
Conclusions
Cultured autologous melanocyte transplantation is an effective treatment for stable vitiligo. Combination of NB‐UVB therapy with melanocyte transplantation can accelerate repigmentation of transplanted vitiliginous areas, especially if NB‐UVB is given before and after transplantation.</description><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1111/dsu.12444</identifier><identifier>PMID: 24446755</identifier><language>eng</language><publisher>United States: by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc</publisher><subject>Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Male ; Melanocytes - transplantation ; Middle Aged ; Transplantation, Autologous ; Ultraviolet Therapy - methods ; Vitiligo - therapy ; Young Adult</subject><ispartof>Dermatologic surgery, 2014-04, Vol.40 (4), p.420-426</ispartof><rights>2014 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3634-9b8930aef4084f99a843c0e21f4732caa712f77f4d1e6eac02483a8a1e7a66393</citedby><cites>FETCH-LOGICAL-c3634-9b8930aef4084f99a843c0e21f4732caa712f77f4d1e6eac02483a8a1e7a66393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdsu.12444$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdsu.12444$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24446755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Di‐min</creatorcontrib><creatorcontrib>Hong, Wei‐song</creatorcontrib><creatorcontrib>Fu, Li‐fang</creatorcontrib><creatorcontrib>Wei, Xiao‐dong</creatorcontrib><creatorcontrib>Xu, Ai‐e</creatorcontrib><title>A Randomized Controlled Study of the Effects of Different Modalities of Narrow‐Band Ultraviolet B Therapy on the Outcome of Cultured Autologous Melanocytes Transplantation in Treating Vitiligo</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><description>Background
Vitiligo is an acquired skin disorder with great social impact. It can be successfully treated using cultured autologous melanocytes transplantation.
Objective
To evaluate the effect of different modalities of narrow‐band ultraviolet B (NB‐UVB) therapy on the outcome of cultured autologous melanocyte transplantation in treating vitiligo.
Methods
Patients undergoing cultured autologous melanocyte transplantation were randomly assigned to four different study groups. Group 1 underwent 20 sessions of NB‐UVB treatment before transplantation; Group 2 underwent 30 sessions of NB‐UVB treatment after transplantation; Group 3 underwent 20 sessions of NB‐UVB treatment before transplantation and 30 sessions after transplantation; Group 4 underwent only transplantation.
Results
Four hundred thirty‐seven patients were enrolled. Group 3 responded best, more than 90% repigmentation was achieved in 81.3% of patients, and 94.8% patients experienced 50% or greater repigmentation. Statistical analysis showed that there was a highly significant difference between the four groups (χ2 = 35.56, p < .001). Homogeneous skin color was obtained on the repigmentation areas, and no scarring or other serious side effects were observed.
Conclusions
Cultured autologous melanocyte transplantation is an effective treatment for stable vitiligo. Combination of NB‐UVB therapy with melanocyte transplantation can accelerate repigmentation of transplanted vitiliginous areas, especially if NB‐UVB is given before and after transplantation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Melanocytes - transplantation</subject><subject>Middle Aged</subject><subject>Transplantation, Autologous</subject><subject>Ultraviolet Therapy - methods</subject><subject>Vitiligo - therapy</subject><subject>Young Adult</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp1kctuEzEUhkeIipbCghdAXsJiWnvsuS3TtAWkXiSasB2dzhwnBs84-NIorHgEnolH4UnwJKEr6o3_Y33nP8f6k-QNoycsntPOhROWCSGeJUcsz0Qqyix_HjUti5TmLDtMXjr3lVKW1Zy-SA5Htijz_Cj5PSGfYehMr35gR6Zm8NZoHeWdD92GGEn8EsmFlNh6N5bnKmqLgyfXpgOtvMLt-w1Ya9Z_fv46i3Zkrr2FB2U0enJGZku0sIpuw9btNvjW9Dh2TYP2wcZxk-CNNgsTHLlGDYNpNz4azywMbhVrD17FdjXEJ4x6WJAvcbZWC_MqOZCgHb7e38fJ_PJiNv2YXt1--DSdXKUtL7hI6_sqfh5QCloJWddQCd5SzJgUJc9agJJlsiyl6BgWCC3NRMWhAoYlFAWv-XHybue7suZ7QOebXrkWddwO494Ny5kQXPB6RN_v0NYa5yzKZmVVD3bTMNqMkTUxsmYbWWTf7m3DfY_dI_kvowikO2BttEfrvumwRtssEbRf_tfwdM8rjZunJzfnd_Ndx1_IGrR5</recordid><startdate>201404</startdate><enddate>201404</enddate><creator>Zhang, Di‐min</creator><creator>Hong, Wei‐song</creator><creator>Fu, Li‐fang</creator><creator>Wei, Xiao‐dong</creator><creator>Xu, Ai‐e</creator><general>by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201404</creationdate><title>A Randomized Controlled Study of the Effects of Different Modalities of Narrow‐Band Ultraviolet B Therapy on the Outcome of Cultured Autologous Melanocytes Transplantation in Treating Vitiligo</title><author>Zhang, Di‐min ; Hong, Wei‐song ; Fu, Li‐fang ; Wei, Xiao‐dong ; Xu, Ai‐e</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3634-9b8930aef4084f99a843c0e21f4732caa712f77f4d1e6eac02483a8a1e7a66393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Melanocytes - transplantation</topic><topic>Middle Aged</topic><topic>Transplantation, Autologous</topic><topic>Ultraviolet Therapy - methods</topic><topic>Vitiligo - therapy</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Di‐min</creatorcontrib><creatorcontrib>Hong, Wei‐song</creatorcontrib><creatorcontrib>Fu, Li‐fang</creatorcontrib><creatorcontrib>Wei, Xiao‐dong</creatorcontrib><creatorcontrib>Xu, Ai‐e</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Di‐min</au><au>Hong, Wei‐song</au><au>Fu, Li‐fang</au><au>Wei, Xiao‐dong</au><au>Xu, Ai‐e</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Randomized Controlled Study of the Effects of Different Modalities of Narrow‐Band Ultraviolet B Therapy on the Outcome of Cultured Autologous Melanocytes Transplantation in Treating Vitiligo</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2014-04</date><risdate>2014</risdate><volume>40</volume><issue>4</issue><spage>420</spage><epage>426</epage><pages>420-426</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><abstract>Background
Vitiligo is an acquired skin disorder with great social impact. It can be successfully treated using cultured autologous melanocytes transplantation.
Objective
To evaluate the effect of different modalities of narrow‐band ultraviolet B (NB‐UVB) therapy on the outcome of cultured autologous melanocyte transplantation in treating vitiligo.
Methods
Patients undergoing cultured autologous melanocyte transplantation were randomly assigned to four different study groups. Group 1 underwent 20 sessions of NB‐UVB treatment before transplantation; Group 2 underwent 30 sessions of NB‐UVB treatment after transplantation; Group 3 underwent 20 sessions of NB‐UVB treatment before transplantation and 30 sessions after transplantation; Group 4 underwent only transplantation.
Results
Four hundred thirty‐seven patients were enrolled. Group 3 responded best, more than 90% repigmentation was achieved in 81.3% of patients, and 94.8% patients experienced 50% or greater repigmentation. Statistical analysis showed that there was a highly significant difference between the four groups (χ2 = 35.56, p < .001). Homogeneous skin color was obtained on the repigmentation areas, and no scarring or other serious side effects were observed.
Conclusions
Cultured autologous melanocyte transplantation is an effective treatment for stable vitiligo. Combination of NB‐UVB therapy with melanocyte transplantation can accelerate repigmentation of transplanted vitiliginous areas, especially if NB‐UVB is given before and after transplantation.</abstract><cop>United States</cop><pub>by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc</pub><pmid>24446755</pmid><doi>10.1111/dsu.12444</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1076-0512 |
| ispartof | Dermatologic surgery, 2014-04, Vol.40 (4), p.420-426 |
| issn | 1076-0512 1524-4725 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1514434399 |
| source | Wiley Blackwell Journals |
| subjects | Adolescent Adult Child Child, Preschool Female Humans Male Melanocytes - transplantation Middle Aged Transplantation, Autologous Ultraviolet Therapy - methods Vitiligo - therapy Young Adult |
| title | A Randomized Controlled Study of the Effects of Different Modalities of Narrow‐Band Ultraviolet B Therapy on the Outcome of Cultured Autologous Melanocytes Transplantation in Treating Vitiligo |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A38%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Randomized%20Controlled%20Study%20of%20the%20Effects%20of%20Different%20Modalities%20of%20Narrow%E2%80%90Band%20Ultraviolet%20B%20Therapy%20on%20the%20Outcome%20of%20Cultured%20Autologous%20Melanocytes%20Transplantation%20in%20Treating%20Vitiligo&rft.jtitle=Dermatologic%20surgery&rft.au=Zhang,%20Di%E2%80%90min&rft.date=2014-04&rft.volume=40&rft.issue=4&rft.spage=420&rft.epage=426&rft.pages=420-426&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1111/dsu.12444&rft_dat=%3Cproquest_cross%3E1514434399%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3634-9b8930aef4084f99a843c0e21f4732caa712f77f4d1e6eac02483a8a1e7a66393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1514434399&rft_id=info:pmid/24446755&rfr_iscdi=true |